A resolution expressing support for the designation of July 15, 2024, as "National Leiomyosarcoma Awareness Day".

This resolution supports the designation of July 15, 2024, as National Leiomyosarcoma Awareness Day.

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 775 Introduced in Senate (IS)]

<DOC>






118th CONGRESS
  2d Session
S. RES. 775

Expressing support for the designation of July 15, 2024, as ``National 
                    Leiomyosarcoma Awareness Day''.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             July 30, 2024

Ms. Stabenow submitted the following resolution; which was referred to 
        the Committee on Health, Education, Labor, and Pensions

_______________________________________________________________________

                               RESOLUTION


 
Expressing support for the designation of July 15, 2024, as ``National 
                    Leiomyosarcoma Awareness Day''.

Whereas leiomyosarcoma is a malignant sarcoma subtype, 1 of 70 to 100 such 
        subtypes, that arises in smooth muscle and has several subtypes itself 
        due to its vascularity and bone invasion;
Whereas leiomyosarcoma is designated by the National Institutes of Health as a 
        rare form of cancer;
Whereas leiomyosarcoma is largely resistant to standard chemotherapy treatments, 
        radiation treatments, and immunotherapy trials, with 40-year-old 
        chemotherapy treatments still in use;
Whereas leiomyosarcoma affects all age groups, including children, young adults, 
        the middle-aged, and the elderly, and all genders;
Whereas leiomyosarcoma is diagnosed in more than 2,000 individuals in the United 
        States each year;
Whereas, with respect to leiomyosarcoma, research and clinical trials remain 
        complicated and extremely costly due to the difficulty of recruiting 
        patients;
Whereas survival and longevity for individuals with leiomyosarcoma has not 
        significantly improved for at least 30 years;
Whereas multidisciplinary care coordination teams, because of their expertise 
        and experience, are critical to the health of leiomyosarcoma patients;
Whereas researchers continue to strive to improve quality of life for 
        leiomyosarcoma patients, improve outcomes in clinical trials, and 
        promote enhanced survivorship; and
Whereas increased education and awareness about sarcoma and leiomyosarcoma will 
        contribute to the well-being of the communities of the United States: 
        Now, therefore, be it
    Resolved, That the Senate--
            (1) supports the designation of July 15, 2024, as 
        ``National Leiomyosarcoma Awareness Day'';
            (2) recognizes the challenges faced by leiomyosarcoma 
        patients; and
            (3) commends the dedication of organizations, volunteers, 
        researchers, and caregivers across the United States working to 
        improve the quality of life of leiomyosarcoma patients and 
        their families.
                                 <all>